|
|
|
Using Indicators to Measure Country Pharmaceutical Situations
|
Dennis Ross-Degnan, Marsha Pierre Jacques, and Anita Wagner of the CCPP collaborated with colleagues at WHO
in the analyses of the 1999 and 2003 assessments of Level I indicators and of Level II indicator surveys conducted
between 2003 and 2004. Data for Level I indicators were provided by national officials in 146 countries. Data to
measure Level II indicators were collected in samples of public health facilities, private pharmacies, and
warehouses by 26 country teams.
The resulting Fact Book summarizes indicator data within groups of countries classified as low, middle, and
high income according to the following eight topics: (1) National medicines policy; (2) Legislation and
regulation; (3) Quality control of pharmaceuticals; (4) Medicines financing systems and policies; (5) Public
sector medicines supply; (6) Intellectual property rights and patents and local production; (7) Access to
essential medicines; and (8) Rational use of medicines. Where comparable data are available from the 1999
Level I indicator survey, the Fact Book describes progress made in country pharmaceutical sector processes
between 1999 and 2003. Level II indicators on access, quality, and rational use of medicines are used to
assess whether outcome targets in these areas are being achieved. WHO TCM supported this work. The full
report is available upon request (email Sarah_Lewis@harvardpilgrim.org).
|
|
LATEST UPDATES
WHOCCPP
awarded funding for Interdisciplinary
Research and Training for Improving
Access to and Use of Medicines in China by Harvard
China Fund
Upcoming Courses
MedIC
Initiative Courses in Accra, Ghana, November 16-25, 2008
and Beijing, China in the Spring of 2009
|
